| Plerixafor studied in …STUDIED_INderived82 of 82show fewer |
|---|
| → studied in | NCT07605416Phase 2 · recruiting Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial · 82 trials list this drug (9 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07775313Phase 1/Phase 2 · enrolling by invitation Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM · 82 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967785Phase 1/Phase 2 · completed A Phase I Study of Mozobil in the Treatment of Patients With WHIMS · 82 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05470491Phase 1/Phase 2 · recruiting Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... · 82 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01318317Phase 1/Phase 2 · active not recruiting Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma · 82 trials list this drug (9 active) | — | — | Non-Hodgkin Lymphoma,Grade 3 Follicular Lymphoma,Mantle Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158828Phase 1/Phase 2 · recruiting Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML · 82 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207799Phase 2 · recruiting Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02231879Phase 2/Phase 3 · completed Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome · 82 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05088356Phase 1 · active not recruiting Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft · 82 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188090Phase 2 · recruiting Mozobil for Autologous Hematopoietic Stem Cell Transplantation · 82 trials list this drug (9 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02570542Phase 2 · active not recruiting Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) · 82 trials list this drug (9 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03746080Phase 2 · completed Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma · 82 trials list this drug (9 active) | — | — | Glioblastoma,Malignant Glioma,Glioblastoma with Primitive Neuronal Component+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526096Phase 1 · completed Stem Cell Transplantation for Patients With Multiple Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04762875Phase 2 · terminated MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies · 82 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04177810Phase 2 · completed Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer · 82 trials list this drug (9 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03406091completed Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141304Phase 2 · unknown Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT · 82 trials list this drug (9 active) | — | — | Adult Acute Lymphoblastic Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240861Phase 1 · terminated Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer · 82 trials list this drug (9 active) | — | — | Malignant Neoplasm,Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01696461Phase 2 · completed A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor · 82 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746173Phase 2 · terminated CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma · 82 trials list this drug (9 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03612466Phase 1 · withdrawn A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy · 82 trials list this drug (9 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04552743Phase 2 · completed MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669669Phase 1/Phase 2 · terminated O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas · 82 trials list this drug (9 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703779Phase 2 · completed Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM) · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01753453Phase 2 · completed An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822770Phase 1/Phase 2 · completed Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin · 82 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04058145Phase 2 · withdrawn AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma · 82 trials list this drug (9 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03506802Phase 1 · withdrawn TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00903968Phase 1/Phase 2 · completed Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277209Phase 1 · terminated To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas · 82 trials list this drug (9 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01146834Phase 3 · completed Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02682953Phase 2 · withdrawn Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers · 82 trials list this drug (9 active) | — | — | Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160354Phase 1/Phase 2 · terminated Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML) · 82 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02179970Phase 1 · completed To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers · 82 trials list this drug (9 active) | — | — | Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01408043NA · terminated Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma · 82 trials list this drug (9 active) | — | — | Anaplastic Large Cell Lymphoma,Hairy Cell Leukemia,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343666Phase 1 · withdrawn HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection · 82 trials list this drug (9 active) | — | — | Adult Hodgkin Lymphoma,Adult Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01977677Phase 1/Phase 2 · completed Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma · 82 trials list this drug (9 active) | — | — | Adult Mixed Glioma,Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered,Adult Giant Cell Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352650Phase 1 · completed Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML) · 82 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01547806Phase 2 · completed Collection of Transplant Stem Cells for Plasma Cell Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01097057Phase 2 · completed Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells · 82 trials list this drug (9 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01339039Phase 1 · terminated Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma · 82 trials list this drug (9 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligodendroglioma,Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244930Phase 2 · unknown Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation · 82 trials list this drug (9 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01403896Phase 2 · completed Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor · 82 trials list this drug (9 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01339572Phase 2 · completed Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation · 82 trials list this drug (9 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02098109Phase 2 · completed Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076270NA · terminated Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · 82 trials list this drug (9 active) | — | — | Hairy Cell Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00241358Phase 1/Phase 2 · completed Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies · 82 trials list this drug (9 active) | — | — | Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158118Phase 2 · completed Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors · 82 trials list this drug (9 active) | — | — | Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00914849Phase 2 · completed Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies · 82 trials list this drug (9 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01288573Phase 1/Phase 2 · completed A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone · 82 trials list this drug (9 active) | — | — | Brain Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01610999Phase 1 · terminated Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation · 82 trials list this drug (9 active) | — | — | Lymphoma,Multiple Myeloma,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01435343Phase 1/Phase 2 · completed Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia · 82 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00906945Phase 1/Phase 2 · completed Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia · 82 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943943Phase 1 · completed Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations · 82 trials list this drug (9 active) | — | — | Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00733824Phase 1/Phase 2 · completed Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma · 82 trials list this drug (9 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01621477Phase 2 · terminated T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant · 82 trials list this drug (9 active) | — | — | Myeloid Sarcoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512252Phase 1/Phase 2 · completed AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia · 82 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01164345Phase 2 · completed Mozobil for Autologous Stem Cell Mobilization · 82 trials list this drug (9 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00998049Phase 2 · completed Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720603no longer available This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant. · 82 trials list this drug (9 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00741780completed Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662). · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00990054Phase 1 · completed Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia · 82 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01738373completed Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation · 82 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00694590Phase 1 · completed Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 82 trials list this drug (9 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01027923Phase 1 · terminated IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) · 82 trials list this drug (9 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767714Phase 3 · completed Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation · 82 trials list this drug (9 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01095757Phase 2 · completed Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection · 82 trials list this drug (9 active) | — | — | Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01301963Phase 3 · terminated Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141543completed Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection · 82 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01225419Phase 2 · completed Mobilization by Plerixafor of Haematopoietic Stem Cells in Children · 82 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01236144Phase 1/Phase 2 · completed A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. · 82 trials list this drug (9 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01655875Phase 1 · terminated AMD3100 for Sensitizing in Allogeneic Blood or Marrow Transplant for Chemotherapy Resistant Pediatric Acute Leukemia · 82 trials list this drug (9 active) | — | — | Childhood Acute Lymphoblastic Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00396383Phase 2 · terminated Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00396968Phase 1/Phase 2 · withdrawn AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS · 82 trials list this drug (9 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00665314Phase 2 · completed Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). · 82 trials list this drug (9 active) | — | — | Lymphoma,Hodgkin Lymphoma,Multiple Myeloma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00741325completed Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610). · 82 trials list this drug (9 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01068301Phase 1 · completed A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation · 82 trials list this drug (9 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02006225Phase 4 · unknown Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. · 82 trials list this drug (9 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01037517Phase 2 · completed Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization · 82 trials list this drug (9 active) | — | — | Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01074060Phase 1 · completed Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma · 82 trials list this drug (9 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01700608completed Prospective Observational Study on Plerixafor After Chemotherapy · 82 trials list this drug (9 active) | — | — | Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042717NA · unknown Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection · 82 trials list this drug (9 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |